SEC Form 4 · accession 0001179110-17-009109
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thadd M Vargas
Officer — SVP, Business Development
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jun 13, 2017 | S | 21,751 | $9.587 | D | 19,816 | D | |
| Common StockF2,F1 | Jun 13, 2017 | S | 19,816 | $9.60 | D | 0 | D | |
| Common StockF1 | Jun 13, 2017 | M | 19,320 | $7.12 | A | 19,320 | D | |
| Common StockF1 | Jun 13, 2017 | M | 45,000 | $6.08 | A | 64,320 | D | |
| Common StockF1 | Jun 13, 2017 | M | 43,000 | $6.11 | A | 107,320 | D | |
| Common StockF1 | Jun 13, 2017 | M | 53,500 | $6.77 | A | 160,820 | D | |
| Common StockF2,F1 | Jun 13, 2017 | S | 160,820 | $9.526 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF3 | $7.12 | Jun 13, 2017 | M | 19,320 | D | — | Jan 14, 2021 | Common Stock | 19,320 | 0 | D |
| Common StockF4 | $6.08 | Jun 13, 2017 | M | 45,000 | D | — | Sep 1, 2021 | Common Stock | 45,000 | 0 | D |
| Common StockF5 | $6.11 | Jun 13, 2017 | M | 43,000 | D | — | Jan 12, 2022 | Common Stock | 43,000 | 0 | D |
| Common StockF6 | $6.77 | Jun 13, 2017 | M | 53,500 | D | — | Feb 7, 2023 | Common Stock | 53,500 | 0 | D |
Explanation of responses
- F1Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
- F2The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
- F319,320 stock options were granted on January 14, 2011 and were exercisable in 48 equal monthly installments.
- F445,000 stock options were granted on September 1, 2011 and were exercisable in 48 equal monthly installments.
- F543,000 stock options were granted on January 12, 2012 and were exercisable in 48 equal monthly installments.
- F653,500 stock options were granted on February 7, 2013 and were exercisable in 48 equal monthly installments.